Buyun Ma

Dr. Buyun Ma


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
XSXuejiao Su
Xuejiao Su
CYCan Yue
Can Yue
WYWanting Yang
Wanting Yang
BMBuyun Ma
Buyun Ma
Purpose: To assess and compare the effectiveness of ultrasound-guided core needle biopsy (CNB) in comparison to repeat fine-needle aspiration(rFNA) for thyroid nodules that yield inconclusive results following the initial fine-needle aspiration (FNA).Methods: A cohort of 471 patients who received an inconclusive cytological diagnosis following the initial FNA were included in this study. These patients subsequently underwent either CNB (n=242) or rFNA (n=229). The inconclusive FNA results encompassed categories I, III, and IV of The Bethesda System for Reporting Thyroid Cytopathology(TBSRTC), as well as the ultrasound images indicating malignancy despite FNA results falling under TBSRTC category II. This study assessed the sampling satisfaction rate, diagnostic efficacy, and complications associated with CNB compared to rFNA. Additionally, the impact of repeat puncture time and nodule size on diagnostic efficacy was analyzed.Results: Following repeat punctures, the satisfaction rate of the CNB sampling was found to be significantly higher than that of rFNA (83.9% vs 66.8%). The diagnostic rate in the CNB group was significantly greater compared to that of the rFNA group (70.7% vs 35.8%). In patients with nodule maximum diameters ranging from 5 mm to 20 mm, the diagnostic accuracy was significantly higher in the CNB group compared to that in the rFNA group. In patients with intervals less than 90 days, between 90 days and one year, the diagnostic rate in the CNB group was found to be higher compared to that in the rFNA group. In CNB, not immediately adjacent to the capsule was a risk factor for nodular puncture bleeding (37.0% vs 22.7%.)Conclusion: CNB demonstrated higher rates of satisfaction and diagnosis compared to the rFNA. The diagnostic effectiveness of CNB was not influenced by the time interval or the size of the thyroid nodule. Therefore, in cases where the initial FNA diagnosis of thyroid nodules is inconclusive, CNB should be considered as a viable option for re-puncture.

3 January 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
LHLing Hao
Ling Hao
YCYang Chen
Yang Chen
XSXuejiao Su
Xuejiao Su
BMBuyun Ma
Buyun Ma
Purpose: To evaluate the diagnostic value of ultrasound radiomics in distinguishing between benign and malignant breast nodules in women who have undergone silicone breast augmentation. Methods: A retrospective study was conducted of 99 breast nodules detected by ultrasound in 93 women who had undergone silicone breast augmentation. The ultrasound data were collected between 1 January 2006 and 1 September 2023. The nodules were allocated into a training set (n = 69) and a validation set (n = 30). Regions of interest (ROIs) were manually delineated using 3D Slicer software, and radiomic features were extracted and selected using Python programming. Eight machine learning algorithms were applied to build predictive models, and their performance was assessed using sensitivity, specificity, area under the ROC curve (AUC), accuracy, Brier score, and log loss. Model performance was further evaluated using ROC curves and calibration curves, while clinical utility was assessed via decision curve analysis (DCA). Results: The random forest model exhibited superior performance in differentiating benign from malignant nodules in the validation set, achieving sensitivity of 0.765, specificity of 0.838, and an AUC of 0.787 (95% CI: 0.561–0.960). The model’s accuracy, Brier score, and log loss were 0.796, 0.197, and 0.599, respectively. DCA suggested potential clinical utility of the model. Conclusion: Ultrasound radiomics demonstrates promising diagnostic accuracy in differentiating benign from malignant breast nodules in women with silicone breast prostheses. This approach has the potential to serve as an additional diagnostic tool for patients following silicone breast augmentation.

19 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
JCJuanmei Chen
Juanmei Chen
ZDZijian Deng
Zijian Deng
YCYong Chen
Yong Chen
RYRuiheng Ye
Ruiheng Ye
JLJiawu Li
Jiawu Li
YHYushuang He
Yushuang He
Background/Objectives: Primary thyroid lymphoma (PTL), including diffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphoma, share substantial overlap in ultrasound appearance with Hashimoto’s thyroiditis (HT), making preoperative differentiation challenging. This study aims to develop and validate a deep learning model based on B-mode ultrasound (BMUS) and color Doppler ultrasound (CDUS) for image-level differentiation of DLBCL, MALT lymphoma, and HT. Methods: This retrospective single-center study included 1294 ultrasound images from 290 patients (313 lesions) who underwent preoperative ultrasound examination at West China Hospital between September 2002 and September 2024. All images from the same lesion were assigned to the same data partition, and the dataset was split at the lesion level into training and test sets at an 8:2 ratio. A Frequency-Adaptive WT-ResNet model incorporating wavelet transform convolution and a frequency-adaptive gating mechanism was developed. The primary analysis was performed at the image level. The performance of the model was compared with that of three ultrasound physicians with different levels of experience. Grad-CAM was used for visual interpretation. An exploratory external validation was performed using an independent dataset from Sun Yat-sen Memorial Hospital. Results: In the test set, the model achieved a macro-average AUC of 0.927 (95% CI: 0.889–0.960), with class-specific AUCs of 0.899 for DLBCL, 0.946 for MALT lymphoma, and 0.937 for HT. The macro-average balanced accuracy was 0.866, compared with 0.827 for that of the best-performing senior physician. The exploratory validation set yielded a macro-average AUC of 0.796 (95% CI: 0.686–0.888), with class-specific AUCs of 0.806 for DLBCL, 0.825 for HT, and 0.756 for MALT lymphoma. Grad-CAM showed that the model focused on lesion-internal echotexture and lesion-transition regions with class-dependent patterns. Conclusions: A deep learning model based on BMUS and CDUS showed promising performance for image-level differentiation of DLBCL, MALT lymphoma and HT in a single-center retrospective cohort. The model outperformed three ultrasound physicians and may serve as a potential decision-support tool. However, the exploratory external validation results should be interpreted as preliminary, and larger multicenter cohorts remain necessary to confirm model generalizability.

1 April 2024 in Chinese Clinical Oncology
Verified
Journal Article
Open access
PDF file
WYWanting Yang
Wanting Yang
MYMing Yin
Ming Yin
JZJiehong Zhou
Jiehong Zhou
YZYun Zhu
Yun Zhu
BYBeibei Ye
Beibei Ye
BMBuyun Ma
Buyun Ma
Background: The current preoperative malignancy risk evaluation for thyroid nodules involves stepwise diagnostic modalities including ultrasonography, thyroid function serology and fine-needle aspiration (FNA) cytopathology, respectively. We aimed to substantiate the stepwise contributions of each diagnostic step and additionally investigate the diagnostic significance of quantitative chromogenic imprinted gene in-situ hybridization (QCIGISH)—an adjunctive molecular test based on epigenetic imprinting alterations. Methods: A total of 114 cytopathologically-diagnosed and histopathologically-confirmed thyroid nodules with complete ultrasonographic and serological examination records were evaluated using QCIGISH in the study. Logistic regression models for thyroid malignancy prediction were developed with the stepwise addition of each diagnostic modality and the contribution of each step evaluated in terms of discrimination performance and goodness-of-fit. Results: From the baseline model using ultrasonography [area under the receiver operating characteristics curve (AUROC): 0.79; 95% confidence interval (CI): 0.71–0.86], significant improvements in thyroid malignancy discrimination were observed with the stepwise addition of thyroid function serology (AUROC: 0.82; 95% CI: 0.74–0.90; P=0.23) and FNA cytopathology (AUROC: 0.88; 95% CI: 0.81–0.94; P=0.02), respectively. The inclusion of QCIGISH as an adjunctive molecular test further advanced the preceding model’s diagnostic performance (AUROC: 0.95; 95% CI: 0.91–1.00, P=0.007). Conclusions: Our study demonstrated the significant stepwise diagnostic contributions of standard clinical assessments in the malignancy risk stratification of thyroid nodules. However, the addition of molecular imprinting detection further enabled a more accurate and definitive preoperative evaluation especially for morphologically indeterminate thyroid nodules and cases with potentially discordant results among standard modalities.

16 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JCJuanmei Chen
Juanmei Chen
ARAyibota Ruxian
Ayibota Ruxian
DLDanying Li
Danying Li
YJYong Jiang
Yong Jiang
BMBuyun Ma
Buyun Ma
Background/Objectives: Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by multisystem infiltration of foamy histiocytes, leading to chronic inflammation, fibrosis, and organ dysfunction. Breast involvement in ECD is extremely uncommon, and the sonographic features of ECD involving the breast remain poorly described. Case Presentation: We report the case of a 59-year-old woman with chronic bone pain and multisystem disease who experienced an extended diagnostic course despite undergoing renal biopsy, biopsy of a right elbow lesion, bone marrow examination, and multidisciplinary evaluation. Breast ultrasound revealed bilateral infiltrative hypoechoic lesions involving the breasts and axillae. These were classified as BI-RADS 4C and were highly suspicious for breast malignancy. Subsequently, an ultrasound-guided core needle biopsy was performed on the breast and axillary lesions. Results: Histopathology showed fibroadipose tissue infiltrated by numerous foamy histiocytes, scattered epithelioid cells, and occasional Touton giant cells. Immunohistochemistry showed positivity for CD68, CD163, CD4, and Cyclin D1, partial positivity for OCT2 and CD30, and negativity for S100, CD1a, Langerin, ALK, CK (Pan), and GATA3. The Ki-67 index was approximately 3%. Molecular testing detected the BRAF V600E mutation, supporting the diagnosis of ECD. A review of reported cases showed that breast involvement in ECD lacks specific ultrasound findings and may closely mimic primary breast malignancy. Conclusions: Breast involvement in ECD is rare and may present as bilateral infiltrative hypoechoic lesions with axillary involvement on ultrasound. In patients with chronic bone pain, symmetric osteosclerosis, or multisystem disease, ECD should be considered in the differential diagnosis. Ultrasound-detected superficial lesions may provide accessible biopsy targets, helping to establish a timely diagnosis and reduce diagnostic delay.